MedPath

Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity

Completed
Conditions
Ectopia Lentis
Marfan Syndrome
Registration Number
NCT04319107
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Marfan syndrome is characterized by musculoskeletal manifestations, cardiovascular disease and ocular abnormalities, particularly ectopia lentis. Diagnosis depends on clinical evaluation, family history and molecular data: mutation in the fibrillin-1 gene (FBN1). Ectopia lentis is the most common ocular manifestation in Marfan syndrome with FBN1 mutation and is relatively specific to this disease when associated with other features. However, clinical examinations for identifying ectopia lentis have not really been codified. The purpose of this study is to describe a 5-grade classification of increasing severity for ectopia lentis based on clinical examination and to evaluate the predictive value for the early grades of ectopia lentis in order to help characterize this major clinical diagnosis criterion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • MFS patient, clinical diagnosis according to revised Ghent criteria, confirmed by FBN1 mutation.
  • Relatives of MFS patients with none of the clinical features of MFS and in whom testing for the familial FBN1 mutation was negative.
Exclusion Criteria
  • Patients who had surgery for ectopia lentis
  • Patients for whom dilation was not optimal.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ectopia lentis measurementday 0

Ectopia lentis measurement and classification into 5-stages. Evaluation of the predictive value of ectopia lentis, at early stages, in order to help characterize this major clinical diagnosis criteria.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hopital Femme Mère Enfant

🇫🇷

Bron, France

Hopital Femme Mère Enfant
🇫🇷Bron, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.